PARP inhibitor News
Most Popular PARP inhibitor Story
PARP inhibitor posts impressive tumor results
An experimental cancer therapy that's one of a new class of PARP inhibitors produced some surprisingly positive results in a small study of cancer victims who share BRCA1 and BRCA2 genetic mutations.... Read more...
Latest Headlines
- June 25, 2009
- June 1, 2009
- April 8, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
